359 related articles for article (PubMed ID: 25082505)
1. Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage.
Wang F; Guo X; Shen X; Kream RM; Mantione KJ; Stefano GB
Med Sci Monit Basic Res; 2014 Aug; 20():118-29. PubMed ID: 25082505
[TBL] [Abstract][Full Text] [Related]
2. Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer's disease.
Leszek J; Sochocka M; Gąsiorowski K
J Neurol Sci; 2012 Dec; 323(1-2):25-32. PubMed ID: 23026534
[TBL] [Abstract][Full Text] [Related]
3. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.
Grammas P
J Neuroinflammation; 2011 Mar; 8():26. PubMed ID: 21439035
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
5. Etiology of type 2 diabetes and Alzheimer's disease: Exploring the mitochondria.
Silzer TK; Phillips NR
Mitochondrion; 2018 Nov; 43():16-24. PubMed ID: 29678670
[TBL] [Abstract][Full Text] [Related]
6. Vascular and metabolic dysfunction in Alzheimer's disease: a review.
Murray IV; Proza JF; Sohrabji F; Lawler JM
Exp Biol Med (Maywood); 2011 Jul; 236(7):772-82. PubMed ID: 21680755
[TBL] [Abstract][Full Text] [Related]
7. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide.
de la Torre JC; Stefano GB
Brain Res Brain Res Rev; 2000 Dec; 34(3):119-36. PubMed ID: 11113503
[TBL] [Abstract][Full Text] [Related]
8. Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.
He JT; Zhao X; Xu L; Mao CY
J Alzheimers Dis; 2020; 73(1):39-58. PubMed ID: 31815697
[TBL] [Abstract][Full Text] [Related]
9. Obesity as a risk factor for Alzheimer's disease: weighing the evidence.
Alford S; Patel D; Perakakis N; Mantzoros CS
Obes Rev; 2018 Feb; 19(2):269-280. PubMed ID: 29024348
[TBL] [Abstract][Full Text] [Related]
10. No evidence of endothelial dysfunction in patients with Alzheimer's disease.
McGleenon BM; Passmore AP; McAuley DF; Johnston GD
Dement Geriatr Cogn Disord; 2000; 11(4):197-201. PubMed ID: 10867445
[TBL] [Abstract][Full Text] [Related]
11. Oxidative toxicity in diabetes and Alzheimer's disease: mechanisms behind ROS/ RNS generation.
Ahmad W; Ijaz B; Shabbiri K; Ahmed F; Rehman S
J Biomed Sci; 2017 Sep; 24(1):76. PubMed ID: 28927401
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease?
Isingrini E; Desmidt T; Belzung C; Camus V
Curr Opin Investig Drugs; 2009 Jan; 10(1):46-55. PubMed ID: 19127486
[TBL] [Abstract][Full Text] [Related]
13. Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.
Di Marco LY; Venneri A; Farkas E; Evans PC; Marzo A; Frangi AF
Neurobiol Dis; 2015 Oct; 82():593-606. PubMed ID: 26311408
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis?
Milionis HJ; Florentin M; Giannopoulos S
CNS Spectr; 2008 Jul; 13(7):606-13. PubMed ID: 18622365
[TBL] [Abstract][Full Text] [Related]
15. Vascular pharmacotherapy and dementia.
Piguet O; Garner B
Curr Vasc Pharmacol; 2010 Jan; 8(1):44-50. PubMed ID: 19485934
[TBL] [Abstract][Full Text] [Related]
16. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
Farkas K; Sármán B; Jermendy G; Somogyi A
Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
[TBL] [Abstract][Full Text] [Related]
17. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelial dysfunction and arterial stiffness in the development of diabetic retinopathy.
Siasos G; Gouliopoulos N; Moschos MM; Oikonomou E; Kollia C; Konsola T; Athanasiou D; Siasou G; Mourouzis K; Zisimos K; Papavassiliou AG; Stefanadis C; Tousoulis D
Diabetes Care; 2015 Jan; 38(1):e9-e10. PubMed ID: 25538324
[No Abstract] [Full Text] [Related]
20. Genetic abnormalities of the endothelium.
Butany JW; Verma S; Leask RL; Mohsen B; Asa SL
Microsc Res Tech; 2003 Jan; 60(1):30-7. PubMed ID: 12500258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
